Streetbeat News

Price Targets

DT

JMP Securities analyst Erik Suppiger maintains a Market Outperform rating on Dynatrace (NYSE:DT) and raises the price target from $50 to $56.

Portfolio Pulse from richadhand@benzinga.com

July 26, 2023 | 12:27 pm

CB

JMP Securities analyst Matthew Carletti has reiterated a 'Market Outperform' rating on Chubb (NYSE:CB) and maintained a price target of $250.

Portfolio Pulse from richadhand@benzinga.com

July 26, 2023 | 12:27 pm

ARE

JMP Securities analyst Aaron Hecht maintains a Market Outperform rating on Alexandria Real Estate (NYSE:ARE) but lowers the price target from $180 to $160.

Portfolio Pulse from richadhand@benzinga.com

July 26, 2023 | 12:25 pm

ARCC

JMP Securities analyst Devin Ryan has reiterated a Market Outperform rating on Ares Capital (NASDAQ:ARCC) and maintained a $20 price target.

Portfolio Pulse from richadhand@benzinga.com

July 26, 2023 | 12:24 pm

ANET

JMP Securities analyst Erik Suppiger maintains a Market Outperform rating on Arista Networks (NYSE:ANET) and raises the price target from $165 to $200.

Portfolio Pulse from richadhand@benzinga.com

July 26, 2023 | 12:23 pm

FND

Wells Fargo analyst Zachary Fadem has maintained an Overweight rating on Floor & Decor Holdings (NYSE:FND) and raised the price target from $110 to $125.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2023 | 12:18 pm

TBI

BMO Capital analyst Jeffrey Silber maintains an Outperform rating on TrueBlue (NYSE:TBI) but has lowered the price target from $21 to $20.

Portfolio Pulse from richadhand@benzinga.com

July 26, 2023 | 12:10 pm

TSX:FM

BMO Capital analyst Jackie Przybylowski has maintained a 'Market Perform' rating on First Quantum Minerals (TSX:FM) and lowered the price target from C$36 to C$35.

Portfolio Pulse from richadhand@benzinga.com

July 26, 2023 | 12:09 pm

CNI

BMO Capital analyst Fadi Chamoun has maintained an 'Outperform' rating on Canadian National Railway (TSX:CNR), but lowered the price target from C$177 to C$175.

Portfolio Pulse from richadhand@benzinga.com

July 26, 2023 | 12:08 pm

BIIB

BMO Capital analyst Evan Seigerman has maintained an 'Outperform' rating on Biogen (NASDAQ:BIIB) but lowered the price target from $357 to $347.

Portfolio Pulse from richadhand@benzinga.com

July 26, 2023 | 12:07 pm